1. Long-Term Survival of a Patient With Non–Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene
   Nathaniel J. Myall et al, 2016, Clinical Lung Cancer CrossRef
2. High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer
   Sören Weidemann et al, 2023, Applied Immunohistochemistry & Molecular Morphology CrossRef
3. BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice
   Maria Sissa Pereira Sant’Ana et al, 2021, Journal of Oral Pathology & Medicine CrossRef
4. Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics
   Jonathan L. Messerschmidt et al, 2017, Current Oncology Reports CrossRef
5. Is time to progression associated with post-progression survival in previously treated metastatic non-small cell lung cancer with BRAF V600E mutation? A secondary analysis of phase II clinical trial data
   Junlong Li et al, 2018, BMJ Open CrossRef
6. Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
   Xiao-xiao Sun et al, 2015, Acta Pharmacologica Sinica CrossRef
7. Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis
   Junlong Li et al, 2018, Advances in Therapy CrossRef